Remimazolam for general anesthesia in a patient with aortic stenosis and severe obesity undergoing transcatheter aortic valve implantation

Remimazolam for general anesthesia in a patient with aortic stenosis and severe obesity undergoing transcatheter aortic valve implantation

Abstract Introduction There is currently limited research on the clinical use of remimazolam in severely obese patients. In this report, we describe the anesthesia management of transcatheter aortic valve implantation (TAVI) in a severely obese patient using remimazolam. Case description A 76-year-o...

Full description

Bibliographic Details
Main Authors: Atsushi Kainuma, Ayaka Koyama, Mao Kinoshita, Jun Iida, Teiji Sawa
Format: Article
Language:English
Published: SpringerOpen 2024-05-01
Series:JA Clinical Reports
Subjects:
Remimazolam
Obesity
Transcatheter Aortic Valve Implantation
General Anesthesia
Aortic valve stenosis
Online Access:https://doi.org/10.1186/s40981-024-00716-1

Internet

https://doi.org/10.1186/s40981-024-00716-1

Similar Items